» Articles » PMID: 15526143

Lack of Association Between Two Polymorphisms of Brain-derived Neurotrophic Factor and Response to Typical Neuroleptics

Overview
Specialties Neurology
Physiology
Date 2004 Nov 5
PMID 15526143
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies have connected brain-derived neurotrophic factor (BDNF) with treatment response to neuroleptics. In recent studies, the BDNF expression was reduced by typical neuroleptics. We conducted a retrospective study on 94 patients with schizophrenia and 98 controls. The BDNF G196A and C270T polymorphisms are not associated with treatment response to typical neuroleptics or with age at first hospitalization. Moreover, these polymorphisms of the BDNF gene are not associated with the risk of schizophrenia.

Citing Articles

Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review.

Liberona A, Jones N, Zuniga K, Garrido V, Zelada M, Silva H Int J Mol Sci. 2024; 25(20).

PMID: 39456983 PMC: 11508575. DOI: 10.3390/ijms252011204.


Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes.

Lv Y, Wen L, Hu W, Deng C, Ren H, Bao Y Metab Brain Dis. 2023; 39(1):147-171.

PMID: 37542622 DOI: 10.1007/s11011-023-01271-x.


Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.

Elsheikh S, Muller D, Pouget J Methods Mol Biol. 2022; 2547:389-425.

PMID: 36068471 DOI: 10.1007/978-1-0716-2573-6_14.


Brain-derived neurotrophic factor and schizophrenia.

Di Carlo P, Punzi G, Ursini G Psychiatr Genet. 2019; 29(5):200-210.

PMID: 31465000 PMC: 7386257. DOI: 10.1097/YPG.0000000000000237.


Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review.

Gillespie A, Samanaite R, Mill J, Egerton A, MacCabe J BMC Psychiatry. 2017; 17(1):12.

PMID: 28086761 PMC: 5237235. DOI: 10.1186/s12888-016-1177-y.